logo

For the Inventor, By the Inventor

Boston, MA, United States of America

Li Chai

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignees: The Brigham and Women's Hospital, Inc., Dana-Farber-Cancer Institute Inc., National University of Singapore. Active years: 2016-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Li Chai. Retrieved from https://idiyas.com/inventor/li-chai-kgj4yt5p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Boston, MA (US) (2016 - 2020)
  • Sudbury, MA (US) (2022 - 2024)

Company Filing History:

goldMedal4 out of 1,429 
 
The Brigham and Women's Hospital, Inc.
 patents
silverMedal2 out of 1,268 
 
Dana-Farber-Cancer Institute Inc.
 patents
bronzeMedal2 out of 857 
 
National University of Singapore
 patents
4. 1 out of 1,562 
 
Agency for Science, Technology and Research
 patents
where one patent can have more than one assignee

Years Active: 2016-2024

Loading Chart...
4 patents (USPTO):Explore Patents
1. 11999729 - Small molecule inhibition of transcription factor SALL4 and uses thereof (2024-06-04),
2. 11530209 - Small molecule inhibition of transcription factor SALL4 and uses thereof (2022-12-20),
3. 10793601 - Therapeutic spalt-like transcription factor 4 (SALL4) peptide (2020-10-06),
4. 9365851 - Spalt-like transcription factor 4 (SALL4) and uses thereof (2016-06-14),

Title: Innovations of Inventor Li Chai

Introduction

Li Chai is a notable inventor based in Boston, MA, who has made significant contributions to the field of pharmaceutical sciences. With a total of four patents to his name, he has focused on developing innovative compounds that target specific transcription factors.

Latest Patents

Among his latest patents is the invention titled "Small molecule inhibition of transcription factor SALL4 and uses thereof." This patent describes compounds that interrupt the function of SALL4, along with pharmaceutical compositions and medical uses of these compounds. This work highlights his commitment to advancing medical treatments through innovative research.

Career Highlights

Li Chai has worked at prestigious institutions, including Brigham and Women's Hospital and the National University of Singapore. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Daniel Geoffrey Tenen and Bee Hui Liu, who have also made significant contributions to their respective fields. Their collaboration has likely enhanced the quality and impact of the research conducted.

Conclusion

Li Chai's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a dedication to improving medical science and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…